Art Levine’s article, “Dark Side of a Bain Success,” is inaccurate, unbalanced and disheartening. Mr. Levine makes treatment seem as though it’s about money. In fact, we believe it’s about helping ...
“CytomX Therapeutics (CTMX) announced updated pipeline priorities and anticipated milestones for 2025. “Our top strategic objective for 2025 is the development of CX-2051, a wholly-owned, ...
Dr Kristen Ciombor discusses utilization of biomarkers and molecular testing in the treatment of patients with CRC. Kristen Ciombor, MD: In terms of molecular testing for colorectal cancer, in early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results